{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:26:24Z","timestamp":1785414384173,"version":"3.56.0"},"reference-count":24,"publisher":"Department of Medicine, Warren Alpert Medical School at Brown University","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>A 36-year-old man with a history of arthritis, initially diagnosed as seronegative rheumatoid arthritis, developed new-onset SLE complicated by HLH and TEN. The patient presented with fevers, abdominal pain, vomiting, fatigue, rash, and significant weight loss. Despite multiple hospital visits and antibiotic treatments, his symptoms persisted. On admission, he exhibited extensive erythema, targetoid macules, full-thickness desquamation, and hemorrhagic crusting, covering about 30% of his body surface area. Laboratory findings revealed pancytopenia, positive ANA, anti-chromatin, dsDNA, hypocomplementemia, elevated ferritin, and hypertriglyceridemia. Skin biopsy showed interface dermatitis with full-thickness necrosis, and bone marrow biopsy confirmed hemophagocytic histiocytosis. The patient was diagnosed with SLE, HLH, and TEN and was treated with high-dose prednisone, IVIG, hydroxychloroquine, and mycophenolate mofetil, leading to significant improvement. This case highlights the complexity of diagnosing and managing concurrent SLE, HLH, and TEN. Early recognition and a multidisciplinary approach are crucial for effective treatment and improved outcomes. The patient\u2019s positive response to immunosuppressive therapy underscores the importance of addressing the underlying autoimmune condition in such complex presentations.<\/jats:p>","DOI":"10.56305\/001c.130831","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T08:01:10Z","timestamp":1743494470000},"source":"Crossref","is-referenced-by-count":1,"title":["A Triple Threat: Acute Systemic Lupus Erythematosus Unveiled with Hemophagocytic Lymphohistiocytosis and Toxic Epidermal Necrolysis"],"prefix":"10.56305","volume":"4","author":[{"given":"Charmi","family":"Shah","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02qk94m81","id-type":"ROR","asserted-by":"publisher"}],"name":"Vancouver Clinic","department":["Division of Rheumatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Cotter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02mqqhj42","id-type":"ROR","asserted-by":"publisher"}],"name":"UW Health University Hospital","department":["Department of Dermatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Yu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Irvine","department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolyn","family":"Wanat","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qqv6244","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical College of Wisconsin","department":["Department of Dermatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Harrington","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qqv6244","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical College of Wisconsin","department":["Department of Pathology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Sabchyshyn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qqv6244","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical College of Wisconsin","department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Umpierrez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Emory University","department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"35509","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7326\/0003-4819-114-5-387","article-title":"The acute lupus hemophagocytic syndrome","volume":"114","author":"K. F. Wong","year":"1991","journal-title":"Annals of internal medicine"},{"key":"ref2","article-title":"Rheumatology","author":"M. Hochberg","year":"2018"},{"issue":"15","key":"ref3","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"M. B. Jordan","year":"2011","journal-title":"Blood"},{"issue":"11","key":"ref4","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.24883","article-title":"Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients","volume":"60","author":"A. Parodi","year":"2009","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"ref5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"J. I. Henter","year":"2007","journal-title":"Pediatric blood & cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"A. H. Filipovich","year":"2009","journal-title":"Hematology American Society of Hematology Education Program"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"J. Schneck","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients","volume":"16","author":"P. E. Gavand","year":"2017","journal-title":"Autoimmunity reviews"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1386-6532(01)00256-6","article-title":"A mu-capture immunoassay for detection of human herpes virus-6 (HHV-6) IgM antibodies in human serum","volume":"25","author":"L. Nielsen","year":"2002","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"11","key":"ref10","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"S. Fukaya","year":"2008","journal-title":"Rheumatology (Oxford, England)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"437282","DOI":"10.1155\/2012\/437282","article-title":"Systemic lupus erythematosus","volume":"2012","author":"C. Putterman","year":"2012","journal-title":"Clinical & developmental immunology"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"e13518","DOI":"10.1111\/ctr.13518","article-title":"Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"R. Pellett Madan","year":"2019","journal-title":"Clin Transplant"},{"issue":"8","key":"ref13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/1346-8138.12925","article-title":"Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"42","author":"M. Aihara","year":"2015","journal-title":"J Dermatol"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"B. H. Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"ref15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"C. Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"ref16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ced.14648","article-title":"Toxic epidermal necrolysis-like lupus","volume":"46","author":"E. J. Roberts","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"ref17","series-title":"Dermatology: Sect. 4. Urticarias, Erythemas, and Purpuras","article-title":"Ch 20: Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis","author":"J. J. Bolognia","year":"2012"},{"issue":"9","key":"ref18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archderm.1987.01660330077013","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome)","volume":"123","author":"J. C. Guillaume","year":"1987","journal-title":"Archives of dermatology"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2133.2011.10705.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature","volume":"166","author":"M. Ziemer","year":"2012","journal-title":"The British journal of dermatology"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2340\/00015555-0785","article-title":"Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients","volume":"90","author":"C. G. Cisneros","year":"2010","journal-title":"Acta dermato-venereologica"},{"issue":"1 Suppl","key":"ref21","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.bbmt.2009.11.014","article-title":"Histiocytic disorders: recent insights into pathophysiology and practical guidelines","volume":"16","author":"A. Filipovich","year":"2010","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"5","key":"ref22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"A. Ravelli","year":"2005","journal-title":"The Journal of pediatrics"},{"issue":"10","key":"ref23","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1002\/art.38769","article-title":"Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"66","author":"S. Davi","year":"2014","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"9927","key":"ref24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/s0140-6736(13)61048-x","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"M. Ramos-Casals","year":"2014","journal-title":"Lancet (London, England)"}],"container-title":["Journal of Brown Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bhm.scholasticahq.com\/article\/130831-a-triple-threat-acute-systemic-lupus-erythematosus-unveiled-with-hemophagocytic-lymphohistiocytosis-and-toxic-epidermal-necrolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:49:19Z","timestamp":1751892559000},"score":1,"resource":{"primary":{"URL":"https:\/\/bhm.scholasticahq.com\/article\/130831-a-triple-threat-acute-systemic-lupus-erythematosus-unveiled-with-hemophagocytic-lymphohistiocytosis-and-toxic-epidermal-necrolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.56305\/001c.130831","relation":{},"ISSN":["2994-5593"],"issn-type":[{"value":"2994-5593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}